https://www.selleckchem.com/pr....oducts/phycocyanobil
Clinical studies that were included evaluated work- or social-related disability as a secondary outcome using subjective rating scales. Functional outcomes in adults with TRD receiving ketamine/esketamine was insufficiently characterized. Available evidence indicates that improvements in general psychosocial functioning is apparent. The association, if any, between symptomatic improvement and functional improvement in TRD, as well as the temporality to improve functioning, are future research vistas. Functional outcomes in adult